Danaher Corporation's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "End-Period-Cash-Flow" stands at 8.55 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2019.
Danaher Corporation's third quarter result of 1.52 Billion USD for the item "End Period Cash Flow" represents a decrease of -48.66 percent compared to it's second quarter result.
Also, Danaher Corporation's third quarter result of 1.52 Billion USD for the item "End Period Cash Flow" represents a decrease of -42.22 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Danaher Corporation's third quarter result of 8.55 Billion USD for the item "End Period Cash Flow" represents a decrease of -11.49 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -52.25 percent compared to the value the year prior.
The 1 year change in percent is -52.25.
The 3 year change in percent is -44.64.
The 5 year change in percent is -75.93.
The 10 year change in percent is -20.07.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - End Period Cash Flow | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - End Period Cash Flow | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - End Period Cash Flow | 172,241,486,586.05 |
![]() | Boston Scientific Corp - End Period Cash Flow | 144,567,730,176.00 |
![]() | Stryker Corporation - End Period Cash Flow | 139,209,850,880.00 |